Organic Letters
Letter
Furthermore, we evaluated the in vitro cytotoxicity of all the
obtained products by the methylthiazoltetrazolium (MTT)
assay on the human hepatoma carcinoma cell (HepG-2),
human cervical cancer cell (Hela), human lung carcinoma cell
(A549), and human skin fibroblasts (HSF) cell lines. The
detailed results are listed in Scheme 8 and Table S2.
ACKNOWLEDGMENTS
■
We thank the National Key Research and Development
Program of China (2016YFA0602900), 1000 Youth Talents
Plan, the Fundamental Research Funds for the Central
Universities (2017ZD060), the National Natural Science
Foundation of China (21472052), the Science and Technology
Program of Guangzhou (201607010306), and the Science
Foundation for Distinguished Young Scholars of Guangdong
Province (2014A030306018) for financial support.
Scheme 8. Anticancer Activity of Compounds 3o, 5g, and 5i
REFERENCES
■
(1) For selected reviews, see: (a) Zhou, Y.; Wang, J.; Gu, Z.; Wang,
S.; Zhu, W.; Acen
Rev. 2016, 116, 422. (b) Vitale, A.; Bongiovanni, R.; Ameduri, B.
Chem. Rev. 2015, 115, 8835. (c) Mishra, S.; Daniele, S. Chem. Rev.
̃
a, J. L.; Soloshonok, V. A.; Izawa, K.; Liu, H. Chem.
Gratifyingly, compounds 5i (IC50 = 11.731 μM) and 5g
(IC50 = 6.718 μM) exhibit potent inhibitory activities against
HepG-2 cell lines, product 5i (IC50 = 3.96 μM) shows high
inhibitory efficiency in A549 cell lines, and compound 3o (IC50
= 11.36 μM) is a powerful cytotoxic agent against these cell
lines except for HepG-2 (Scheme 8). This study has
demonstrated the potential of hydroxyhexafluoroisopropyl
anilines in the discovery of new potent anticancer agents.
In summary, we have developed a new cobalt-catalyzed
selective functionalization of aniline derivatives with hexa-
fluoroisopropanol, which enables to access a wide array of
fluoroalkylated anilines, a class of highly valuable building
blocks for further preparation of fluorinated functional
products. The catalytic transformation proceeds with good
functional group and substrate compability, high regio and
chemoselectivity, mild conditions, and operational simplicity,
which offers the potential for the discovery of functional
molecules such as new anticancer agents and sheds new light
on further introduction of other fluoroalkyl groups into
electron-rich organic systems via a radical-coupling strategy.
́
́
2015, 115, 8379. (d) Wang, J.; Sanchez-Rosello, M.; Acena, J. L.; del
̃
Pozo, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H.
Chem. Rev. 2014, 114, 2432. (e) Purser, S.; Moore, P. R.; Swallow, S.;
Gouverneur, V. Chem. Soc. Rev. 2008, 37, 320. (f) Purser, S.; Moore,
P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37, 320.
(2) (a) Domino, K.; Veryser, C.; Wahlqvist, B. A.; Gaardbo, C.;
Neumann, K. T.; Daasbjerg, K.; De Borggraeve, W. M.; Skrydstrup, T.
Angew. Chem., Int. Ed. 2018, 57, 6858. (b) Xu, Z.-B.; Hang, Z. J.; Chai,
L.; Liu, Z.-Q. Org. Lett. 2016, 18, 4662.
(3) (a) Li, L.; Liu, J.; Zhu, L.; Cutler, S.; Hasegawa, H.; Shan, B.;
Medina, J. C. Bioorg. Med. Chem. Lett. 2006, 16, 1638. (b) Kumar, N.;
Solt, L. A.; Conkright, J. J.; Wang, Y.; Istrate, M. A.; Busby, S. A.;
Garcia-Ordonez, R. D.; Burris, T. P.; Griffin, P. R. Mol. Pharmacol.
2010, 77, 228. (c) Wang, Y.; Kumar, N.; Nuhant, P.; Cameron, M. D.;
Istrate, M. A.; Roush, W. R.; Griffin, P. R.; Burris, T. P. ACS Chem.
Biol. 2010, 5, 1029. (d) Bourbeau, M. P.; Ashton, K. S.; Yan, J.; St.
Jean, D. J., Jr J. Org. Chem. 2014, 79, 3684. (e) Li, Y.; Xia, G.; Guo,
Q.; Wu, L.; Chen, S.; Yang, Z.; Wang, W.; Zhang, Z.-Y.; Zhou, X.;
Jiang, Z.-X. MedChemComm 2016, 7, 1672. (f) Peng, Q.; Yuan, Y.;
Zhang, H.; Bo, S.; Li, Y.; Chen, S.; Yang, Z.; Zhou, X.; Jiang, Z.-X.
Org. Biomol. Chem. 2017, 15, 6441.
(4) (a) Cassidy, P. E.; Aminabhavi, T. M.; Reddy, V. S.; Fitch, J. W.,
III Eur. Polym. J. 1995, 31, 353. (b) Fitch, J. W.; Bucio, E.; Martinez,
L.; Macossay, J.; Venumbaka, S. R.; Dean, N.; Stoakley, D.; Cassidy,
P. E. Polymer 2003, 44, 6431. (c) Miyasaka, M.; Koike, N.; Fujiwara,
Y.; Kudo, H.; Nishikubo, T. Polym. J. 2011, 43, 325.
(5) (a) Morikawa, S.; Michigami, K.; Amii, H. Org. Lett. 2010, 12,
2520. (b) O’Reilly, M. E.; Ghiviriga, I.; Abboud, K. A.; Veige, A. S. J.
Am. Chem. Soc. 2012, 134, 11185. (c) Ratjen, L.; van Gemmeren, M.;
Pesciaioli, F.; List, B. Angew. Chem., Int. Ed. 2014, 53, 8765.
(6) (a) Kong, L.; Wang, J.; Fu, X.; Zhong, Y.; Meng, F.; Luo, T.; Liu,
J. Carbon 2010, 48, 1262. (b) Kong, L.; Wang, J.; Luo, T.; Meng, F.;
Chen, X.; Li, M.; Liu, J. Analyst 2010, 135, 368.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Experimental details, NMR spectra, and single-crystal X-
ray diffraction data of 3a (PDF)
Accession Codes
CCDC 1875943 contains the supplementary crystallographic
data for this paper. These data can be obtained free of charge
bridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
́
(7) (a) Lenormand, H.; Corce, V.; Sorin, G.; Chhun, C.;
Chamoreau, L.-M.; Krim, L.; Zins, E.-L.; Goddard, J.-P.;
Fensterbank, L. J. Org. Chem. 2015, 80, 3280. (b) Perozzi, E. F.;
Martin, J. J. Am. Chem. Soc. 1979, 101, 1591.
(8) (a) Mintzer, M. A.; Simanek, E. E. Chem. Rev. 2009, 109, 259.
(b) Birch, A. M.; Groombridge, S.; Law, R.; Leach, A. G.; Mee, C. D.;
Schramm, C. J. Med. Chem. 2012, 55, 3923. (c) Hutchby, M. Novel
Synthetic Chemistry of Ureas and Amides; Springer: Berlin, 2012.
(9) (a) Zelenin, A.; Chkanikov, N.; Umnov, A.; Kolomiets, A.;
Fokin, A. Bull. Acad. Sci. USSR, Div. Chem. Sci. 1986, 35, 1890.
(b) Matsuno, K.; Ueda, Y.; Fukuda, M.; Onoda, K.; Waki, M.; Ikeda,
M.; Kato, N.; Miyachi, H. Bioorg. Med. Chem. Lett. 2014, 24, 4276.
(c) Satou, M.; Kakizawa, T. WO2014133048A1, 2014.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Notes
(10) (a) Chen, X.-W.; Zhao, H.; Chen, C.-L.; Jiang, H.-F.; Zhang, M.
Angew. Chem., Int. Ed. 2017, 56, 14232. (b) Xie, F.; Chen, Q.-H.; Xie,
R.; Jiang, H.-F.; Zhang, M. ACS Catal. 2018, 8, 5869. (c) Liang, T.;
Tan, Z.; Zhao, H.; Chen, X.; Jiang, H.; Zhang, M. ACS Catal. 2018, 8,
2242. (d) Chen, X.; Zhao, H.; Chen, C.; Jiang, H.; Zhang, M. Chem.
Commun. 2018, 54, 9087. (e) Chen, X.; Zhao, H.; Chen, C.; Jiang, H.;
The authors declare no competing financial interest.
D
Org. Lett. XXXX, XXX, XXX−XXX